Which has grown faster, MRNA or VEEV?

Over the past five years, VEEV grew revenue faster — MRNA at a -2.60% CAGR versus VEEV at 16.28%.

Is MRNA or VEEV more profitable?

VEEV runs the higher net margin — MRNA at -143.55% versus VEEV at 28.37%.

Which has been the better investment, MRNA or VEEV?

Over the past 5-year, VEEV delivered the higher annualized total return — MRNA at -25.58% versus VEEV at 16.69%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Veeva Systems Inc. (VEEV)

VEEV leads on 8 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and Veeva Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — MRNA vs VEEV

growth of $100 · last 8y

MRNA +168.3%VEEV +80.1%MRNA compounded faster

MRNA VEEV

MRNA vs VEEV: by the numbers

•VEEV is the larger company ($25.92B vs $19.80B market cap).
•VEEV is profitable (28.37% net margin) while MRNA runs a net loss (-143.55%).
•VEEV grew revenue faster over the past five years (16.28% vs -2.60% CAGR).

Which is better, MRNA or VEEV?

Metric tally: MRNA 2 · VEEV 8

It depends on what you're optimizing for:

GrowthVEEV(faster 5Y revenue CAGR)

QualityVEEV(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	VEEV
P/E ratio	—	28.44
Forward P/E	—	15.91
P/S ratio	8.86	7.98●
P/B ratio	2.66●	3.63
PEG ratio	—	1.42
EV / EBITDA	—	19.17
FCF yield	—	6.21%

Profitability

Metric	MRNA	VEEV
Gross margin	-13.89%	74.95%●
Operating margin	-153.35%	28.79%●
Net margin	-143.55%	28.37%●
ROE	-43.12%	12.89%●
ROIC	-29.70%	9.48%●

Growth (annualized)

Metric	MRNA	VEEV
Revenue CAGR (5Y)	-2.60%	16.28%●
EPS CAGR (5Y)	—	17.11%
FCF CAGR (5Y)	126.92%●	17.43%
Total return CAGR (5Y)	-25.58%	-11.81%●

Frequently asked

Which is better, MRNA or VEEV?: It depends on your goal. growth: VEEV (faster 5Y revenue CAGR); quality: VEEV (higher ROIC). Across all compared metrics, VEEV leads 8 to 2.
Which has grown faster, MRNA or VEEV?: Over the past five years, VEEV grew revenue faster — MRNA at a -2.60% CAGR versus VEEV at 16.28%.
Is MRNA or VEEV more profitable?: VEEV runs the higher net margin — MRNA at -143.55% versus VEEV at 28.37%.
Which has been the better investment, MRNA or VEEV?: Over the past 5-year, VEEV delivered the higher annualized total return — MRNA at -25.58% versus VEEV at 16.69%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full VEEV analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Veeva Systems P/E ratio Moderna dividend yield Veeva Systems dividend yield Moderna ROE Veeva Systems ROE Moderna operating margin Veeva Systems operating margin Moderna revenue growth Veeva Systems revenue growth Moderna free cash flow Veeva Systems free cash flow

Moderna & Veeva Systems appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.